These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2356453)

  • 1. Verapamil-digoxin interaction in chronic hemodialysis patients.
    Rendtorff C; Johannessen AC; Halck S; Klitgaard NA
    Scand J Urol Nephrol; 1990; 24(2):137-9. PubMed ID: 2356453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of coadministration of verapamil and quinidine on serum digoxin concentration.
    Doering W
    Eur J Clin Pharmacol; 1983; 25(4):517-21. PubMed ID: 6653647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digoxin-verapamil interaction: reduction of biliary but not renal digoxin clearance in humans.
    Hedman A; Angelin B; Arvidsson A; Beck O; Dahlqvist R; Nilsson B; Olsson M; Schenck-Gustafsson K
    Clin Pharmacol Ther; 1991 Mar; 49(3):256-62. PubMed ID: 2007320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digoxin-verapamil interaction.
    Pedersen KE; Dorph-Pedersen A; Hvidt S; Klitgaard NA; Nielsen-Kudsk F
    Clin Pharmacol Ther; 1981 Sep; 30(3):311-6. PubMed ID: 7273594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quinidine-digoxin interaction: evidence for involvement of an extrarenal mechanism.
    Doering W; Fichtl B; Herrmann M; Besenfelder E
    Eur J Clin Pharmacol; 1982; 21(4):281-5. PubMed ID: 7056272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The long-term effect of verapamil on plasma digoxin concentration and renal digoxin clearance in healthy subjects.
    Pedersen KE; Dorph-Pedersen A; Hvidt S; Klitgaard NA; Pedersen KK
    Eur J Clin Pharmacol; 1982; 22(2):123-7. PubMed ID: 7094982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of verapamil and isradipine on steady-state digoxin kinetics.
    Rodin SM; Johnson BF; Wilson J; Ritchie P; Johnson J
    Clin Pharmacol Ther; 1988 Jun; 43(6):668-72. PubMed ID: 2967742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P-glycoprotein system as a determinant of drug interactions: the case of digoxin-verapamil.
    Verschraagen M; Koks CH; Schellens JH; Beijnen JH
    Pharmacol Res; 1999 Oct; 40(4):301-6. PubMed ID: 10527640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Digitalis intoxication: specifity and significance of cardiac and extracardiac symptoms. part II. Patients with extracardiac symptoms of digitalis intoxications (author's transl)].
    Doering W; König E; Sturm W
    Z Kardiol; 1977 Mar; 66(3):129-37. PubMed ID: 857453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of verapamil on serum digoxin concentration.
    Klein HO; Lang R; Weiss E; Di Segni E; Libhaber C; Guerrero J; Kaplinsky E
    Circulation; 1982 May; 65(5):998-1003. PubMed ID: 7074765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of the digoxin-quinidine and digoxin-verapamil interactions in the rat kidney.
    Koren G; MacLeod SM
    Res Commun Chem Pathol Pharmacol; 1984 Jul; 45(1):3-18. PubMed ID: 6473899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of verapamil on the inotropism and pharmacokinetics of digoxin.
    Pedersen KE; Thayssen P; Klitgaard NA; Christiansen BD; Nielsen-Kudsk F
    Eur J Clin Pharmacol; 1983; 25(2):199-206. PubMed ID: 6628501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of clinically relevant drug-drug interaction between empagliflozin, a sodium glucose cotransporter 2 inhibitor, and verapamil, ramipril, or digoxin in healthy volunteers.
    Macha S; Sennewald R; Rose P; Schoene K; Pinnetti S; Woerle HJ; Broedl UC
    Clin Ther; 2013 Mar; 35(3):226-35. PubMed ID: 23497760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verapamil and digoxin: interactions in the rat.
    Kaplanski J; Weinhouse E; Topaz M; Genchik G
    Res Commun Chem Pathol Pharmacol; 1983 Dec; 42(3):377-88. PubMed ID: 6665298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanism of the verapamil-digoxin interaction in renal tubular cells (LLC-PK1).
    Ito S; Woodland C; Harper PA; Koren G
    Life Sci; 1993; 53(24):PL399-403. PubMed ID: 8246676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digoxin-verapamil interaction: in vitro studies in rat tissue.
    Koren G; Soldin S; MacLeod SM
    J Cardiovasc Pharmacol; 1983; 5(3):443-5. PubMed ID: 6191144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of serum concentration-guided digoxin therapy on mortality of heart failure patients: A long-term follow-up, propensity-matched cohort study.
    Muk B; Vámos M; Bógyi P; Szabó B; Dékány M; Vágány D; Majoros Z; Borsányi T; Duray GZ; Kiss RG; Nyolczas N
    Clin Cardiol; 2020 Dec; 43(12):1641-1648. PubMed ID: 33140454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digoxin elimination in a functionally anephric patient after digoxin-specific Fab fragment therapy.
    Nuwayhid NF; Johnson GF
    Ther Drug Monit; 1989 Nov; 11(6):680-5. PubMed ID: 2595749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between verapamil and digoxin in Langendorff-perfused rat hearts: the role of inhibition of P-glycoprotein in the heart.
    Aylin Arici M; Kilinc E; Demir O; Ates M; Yesilyurt A; Gelal A
    Basic Clin Pharmacol Toxicol; 2010 Nov; 107(5):847-52. PubMed ID: 22545967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quinidine-digoxin interaction: cardiac efficacy of elevated serum digoxin concentration.
    Belz GG; Doering W; Aust PE; Heinz M; Matthews J; Schneider B
    Clin Pharmacol Ther; 1982 May; 31(5):548-54. PubMed ID: 7075104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.